Sunglow Lifescience Private Limited - Company Profile

It is a pharma private limited company based in Tambaram, Tamil Nadu, India, established in 2012.
2012 Tambaram, Tamil Nadu, India Active
Last Updated:
Access Report
About Sunglow Lifescience Private Limited

Sunglow Lifescience Private Limited, a active private limited company, was established on 01 October 2012 in Tambaram, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TN2012PTC087894. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹21.00 Cr and a paid-up capital of ₹20.45 Cr.

It upholds a compliant status. Employing 109 professional, Its leadership includes Veerabadran Rajasekaran (Director), S Arvind Bhandari (Director), Rajasekar Nagamallu (Director). Past directors included Veerabadran Rajasekaran, S Arvind Bhandari, Kandoth Kunnumpreth Vinupal. It holds ₹18.64 Cr open charges and ₹13.45 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 8Th Floor, Kaleesuwari Towers, No 10/98A, Pace Aagam Apartments, Velachery Main Road Ranganathapuram, Tambaram, Tamil Nadu, 600100.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TN2012PTC087894

  • Registration Number

    087894

  • Incorporation Date

    01 October 2012

  • Authorized Capital

    ₹21.00 Cr

  • Paid-Up Capital

    ₹20.45 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 21.00 Cr
  • Paid Up Capital ₹ 20.45 Cr
  • Company Age 13 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 18.64 Cr
  • Satisfied Charges ₹ 13.45 Cr
  • Revenue Growth **** 20.95%
  • Profit Growth **** 48.83%
  • Ebitda **** 31.02%
  • Net Worth 9.67%
  • Total Assets **** 6.78%
Company report

Sunglow Lifescience Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sunglow Lifescience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sunglow Lifescience Private Limited?
Current Directors
Name Designation Appointment Date Status
Veerabadran Rajasekaran Director 09 Sep 2013 Current
S Arvind Bhandari Director 28 Nov 2013 Current
Rajasekar Nagamallu Director 28 Jul 2021 Current
Kamaraj Director 01 Oct 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2013 Past
Pramod Abcsdd Additional Director 29 Sep 2014 Past
Pramod Abcsdd Director 31 Mar 2018 Past
Pramod Abcsdd Additional Director 10 Nov 2021 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sunglow Lifescience.

Sunglow Lifescience Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 20.95% increase. The company also saw a substantial improvement in profitability, with a 48.83% increase in profit. The company's net worth moved up by a moderate rise of 9.67%.

Sunglow Lifescience revenue growth over time
Sunglow Lifescience profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 20.95%
*******
*******
*******
*******
Revenue from Operations
*******
 20.93%
*******
*******
*******
*******
Total Assets
*******
 6.78%
*******
*******
*******
*******
Profit or Loss
*******
 48.83%
*******
*******
*******
*******
Net Worth
*******
 9.67%
*******
*******
*******
*******
EBITDA
*******
 31.02%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sunglow Lifescience?

In 2024, Sunglow Lifescience had a promoter holding of 13.69% and a public holding of 86.31%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹186,369,030.00

Satisfied Charges

₹134,500,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 18.26 Cr
  • Hdfc Bank Limited : 0.38 Cr
Latest Charge Details
Date Lender Amount Status
04 Apr 2025 Hdfc Bank Limited ₹3.77 M Open
23 Jul 2020 Axis Bank Limited ₹18.26 Cr Open
28 Feb 2017 Axis Bank Limited ₹13.45 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sunglow Lifescience?

Sunglow Lifescience has a workforce of 109 employees as of Mar 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sunglow Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunglow Lifescience's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sunglow Lifescience
Recent Activity within the Organization
  • Annual General Meeting

    Sunglow Lifescience Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 18.26 Cr registered on 23 Jul 2020 with Charge ID 100360500 was modified on 12 Aug 2025. was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.38 Cr with Charge ID 101098270 was registered on 04 Apr 2025. was completed.

  • Balance Sheet

    The activity Sunglow Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.

  • Director Appointment

    Narayanan Agaram Seetharaman was appointed as a Company Secretary was appointed as a Company Secretary on 24 Mar 2025 & has been associated with this company since 11 months 9 days . was recorded as a recent event.

  • Charges

    The activity A charge registered on 28 Feb 2017 via Charge ID 100087370 with Axis Bank Limited was fully satisfied on 14 Mar 2025. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sunglow Lifescience Private Limited?

The CIN of Sunglow Lifescience Private Limited is U24100TN2012PTC087894.

Where is Sunglow Lifescience Private Limited headquartered?

Sunglow Lifescience Private Limited is headquartered at 8Th Floor, Kaleesuwari Towers, No 10/98A, Pace Aagam Apartments, Velachery Main Road Ranganathapuram, Tambaram, Tamil Nadu, 600100.

When was Sunglow Lifescience Private Limited incorporated?

Sunglow Lifescience Private Limited was incorporated on 01 October 2012.

Who are the current directors of Sunglow Lifescience Private Limited?

The current directors of Sunglow Lifescience Private Limited are

What is the primary industry of Sunglow Lifescience Private Limited?

The primary industry of Sunglow Lifescience Private Limited is Manufacturing.

Is Sunglow Lifescience Private Limited a listed company?

Sunglow Lifescience Private Limited is unlisted.

What is the capital structure of Sunglow Lifescience Private Limited?

The authorized capital of Sunglow Lifescience Private Limited is ₹21.00 Cr, and the paid-up capital is ₹20.45 Cr.

What is the compliance status of Sunglow Lifescience Private Limited?

The compliance status of Sunglow Lifescience Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available